OBJECTIVE@#To explore the
prevalence and related factors of
osteoarthritis in
patients with
type 2 diabetes mellitus, and provided a scientific basis for the prevention of the
comorbidity.@*
METHODS@#The data were obtained from the database of all designated medical institutions in
Beijing from 2015 to 2017. Data of the
adult patients with
type 2 diabetes mellitus were collected for descriptive
analysis, and a
Logistic regression model was used to explore the related factors of
osteoarthritis in the
patients with
type 2 diabetes mellitus.@*RESULTS@#A total of 1 046 264 diagnosed
type 2 diabetes mellitus adult patients were included in our study, with an average age of 63.07 years, and 50.78% were
males. Among the
patients with
type 2 diabetes mellitus, there were 341 561 cases with
osteoarthritis, and the
prevalence of
osteoarthritis was 32.65%. The
prevalence of
females (38.05%) was higher than that of
males (27.41%), and the difference was statistically significant (P < 0.05).
Osteoarthritis occurred in all
age groups among the
patients with
type 2 diabetes mellitus, with the highest
prevalence of
osteoarthritis in the
age group of 65-69 years (36.76%), and the lowest
prevalence in the
age group ≤44 years (14.3%). Before the age of 70, the
prevalence increased with age. Further
analysis of related factors for
osteoarthritis in the
patients with
type 2 diabetes mellitus showed that
female (OR=1.62, 95%CI 1.61-1.63), age (OR=1.01, 95%CI 1.01-1.01), had other comorbidities (OR=1.19, 95%CI 1.18-1.21), used
hypoglycemic drugs (OR=0.79, 95%CI 0.78-0.80), having the
cardiovascular disease (OR=1.13, 95%CI 1.11-1.15), having
cerebrovascular disease (OR=1.25, 95%CI 1.23-1.28), and having nephropathy (OR=1.61, 95%CI 1.51-1.71) were associated with the
osteoarthritis in the type 2 diabetic mellitus
patients.@*CONCLUSION@#Our study revealed that the
prevalence of
osteoarthritis in
patients with
type 2 diabetes mellitus is high in
Beijing area.
Health education and
disease monitoring should be strengthened in middle-
aged and
elderly patients.
Screening for comorbidities should be carried out as soon as possible, with the focus on menopausal
women.